ISSN: 1747-6348

Journal Home

Journal Guideline

Expert Review of Respiratory Medicine Q2 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Respiratory Medicine is a journal indexed in SJR in Immunology and Allergy and Public Health, Environmental and Occupational Health with an H index of 62. It has a price of 4000 €. It has an SJR impact factor of 0,825 and it has a best quartile of Q2. It has an SJR impact factor of 0,825.

Expert Review of Respiratory Medicine focuses its scope in these topics and keywords: pulmonary, approachesthe, asthma, cystic, fibrosis, mechanisms, therapeutic, air, antibiotic, apnea, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Immunology and Allergy (Q2) Public Health, Environmental and Occupational Health (Q2) Pulmonary and Respiratory Medicine (Q2)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,825

SJR Impact factor

62

H Index

98

Total Docs (Last Year)

381

Total Docs (3 years)

8118

Total Refs

1076

Total Cites (3 years)

357

Citable Docs (3 years)

2.48

Cites/Doc (2 years)

82.84

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Immunology Q2
Inflammation Q2
International Reviews of Immunology Q2
Journal of Innate Immunity Q2
Immunology and Cell Biology Q2

Compare this journals

Aims and Scope

Best articles by citations

Viral infection and aging as cofactors for the development of pulmonary fibrosis

Adherence to therapies in cystic fibrosis: a targeted literature review

Microorganism-induced suppression of allergic airway disease: novel therapies on the horizon?

Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease

Challenge of exercise-induced asthma and exercise-induced bronchoconstriction

Nocturnal non-invasive positive pressure ventilation for COPD

IntroducingExpert Review of Respiratory Medicine

Advances in cardiorespiratory physiotherapy and their clinical impact

Pulmonary sarcoidosis: diagnostic and treatment update

Treatment of tuberculosis

Risks associated with lung transplantation in cystic fibrosis patients

Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy

SHOW MORE ARTICLES

Genetic basis for personalized medicine in asthma

Reactive species and pulmonary edema

Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis

Epithelial cell fate following lung injury

Influenza vaccination of healthcare workers, oseltamivir resistance and prepandemic vaccination

Beta-blockers in asthma: myth and reality

Congenital central hypoventilation syndrome: diagnosis and management

The relationship between allergen immunotherapy and omalizumab for treating asthma

Circulating progenitor cells in chronic lung disease

Salmeterol/fluticasone propionate combination in the treatment of COPD

Working for a world where all people can breathe freely

Optimal mechanical ventilation strategies to minimize ventilator-induced lung injury in non-injured and injured lungs